Raymond James Trust N.A. Catalent, Inc. Transaction History

Raymond James Trust N.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	SELL	$87.2 - $114.05 $163,761 - $214,185	-1,878 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$94.19 - $124.49 $15,729 - $20,789	-167 Reduced 8.17%	1,878 $208,000
Q4 2021 Jan 31, 2022	BUY	$119.57 - $139.07 $19,729 - $22,946	165 Added 8.78%	2,045 $262,000
Q3 2021 Oct 18, 2021	SELL	$109.17 - $142.35 $22,707 - $29,608	-208 Reduced 9.96%	1,880 $250,000
Q2 2021 Jul 20, 2021	SELL	$100.34 - $115.69 $4,113 - $4,743	-41 Reduced 1.93%	2,088 $226,000
Q1 2021 May 03, 2021	SELL	$101.51 - $125.27 $34,513 - $42,591	-340 Reduced 13.77%	2,129 $224,000
Q4 2020 Jan 13, 2021	SELL	$85.88 - $105.36 $38,302 - $46,990	-446 Reduced 15.3%	2,469 $257,000
Q3 2020 Oct 14, 2020	SELL	$72.74 - $92.5 $13,966 - $17,760	-192 Reduced 6.18%	2,915 $250,000
Q2 2020 Jul 16, 2020	BUY	$48.02 - $79.04 $149,198 - $245,577	3,107 New	3,107 $228,000

16.8M

10.7K

53.4K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

Stay updated on Raymond James Trust N.A. with notifications on news.